Note: These presentations are not eligible for CME credits.
Topic: Optimizing Treatment with Lenvatinib in RAI-DTC.
Speaker: Dr Kate Newbold, Consultant Clinical Oncologist, Royal Marsden London, UK
Title and agenda: TBC
There are outstanding opportunities for industry participation. For more details on the available sponsorship and exhibitor options, please contact:
Rebecca Darling, rebecca@bayleygroup.com Call: +1. 519.263.5050 / +1. 519.263.6001 (direct) Toll Free: 1.888.527.3434 (North America only) |
Cass Bayley cass@bayleygroup.com Call: +1. 519.263.5050 / +1. 519.263.6000 (direct) Toll Free: 1.888.527.3434 (North America only) |